Director/PDMR Shareholding

Ananda Pharma PLC

06 February 2025

 

06 February  2025

ANANDA PHARMA PLC

("Ananda" or the "Company")

 Director/PDMR Shareholding

Ananda announces that on 06 February 2025, Melissa Sturgess, the Company's Chief Executive Officer, purchased 5,000,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares") at a price of 0.43p per Ordinary Share.

After this transaction, Melissa Sturgess has a beneficial interest in 427,382,284 Ordinary Shares, representing 10.04% of the issued share capital of Ananda.

About Ananda Pharma

Ananda Pharma (AQSE: ANA), is a UK-based developer of licenced, cannabinoid medicines targeting the treatment of complex, chronic conditions. The Company is led by successful entrepreneurs and a team of world-class scientists.

For more information, please visit: www.anandapharma.co.uk

To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:  

·              Investor Hub: https://investors.anandapharma.co.uk/s/ea8f93

·              Instagram: https://www.instagram.com/anandapharmaplc/

·              LinkedIn:  https://www.linkedin.com/company/anandapharma

·              X: https://twitter.com/AnandaPlc

·              Investor Meet Company: https://www.investormeetcompany.com/ananda-pharma-plc/register-investor

-Ends-  

The Directors of the Company accept responsibility for the contents of this announcement.  

ANANDA PHARMA PLC	[phone]
	[e-mail]
Chief Executive Officer
Melissa Sturgess
Finance Director
Jeremy Sturgess-Smith
SP ANGEL CORPORATE FINANCE LLP	[phone]
Corporate Finance
Richard Morrison
Corporate Broking
Abigail Wayne
Rob Rees
Yellow Jersey PR (media enquiries) Sarah MacLeod Charles Goodwin Zara McKinlay	[phone] [e-mail]

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Melissa Sturgess
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Ananda Pharma plc
b)	LEI	894500DFM8VOC5FW4X47
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares ISIN: GB00BDQPXQ60
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	5,000,000 Ordinary Shares at 0.43p per share
d)	Aggregated information - Aggregated volume - Price	N/A
e)	Date of the transaction	06 February  2025
f)	Place of the transaction	Off Market

https://investors.anandapharma.co.uk/link/pegKZe

 

END